197 related articles for article (PubMed ID: 23638631)
41. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.
Fraser IS; Parke S; Mellinger U; Machlitt A; Serrani M; Jensen J
Eur J Contracept Reprod Health Care; 2011 Aug; 16(4):258-69. PubMed ID: 21774563
[TBL] [Abstract][Full Text] [Related]
42. Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
Wiegratz I; Kutschera E; Lee JH; Moore C; Mellinger U; Winkler UH; Kuhl H
Contraception; 2003 May; 67(5):361-6. PubMed ID: 12742558
[TBL] [Abstract][Full Text] [Related]
43. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
[TBL] [Abstract][Full Text] [Related]
44. Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
Kangasniemi MH; Arffman RK; Haverinen A; Luiro K; Hustad S; Heikinheimo O; Tapanainen JS; Piltonen TT
Contraception; 2022 Dec; 116():59-65. PubMed ID: 36084710
[TBL] [Abstract][Full Text] [Related]
45. A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea.
Uysal G; Akkaya H; Cagli F; Tutus S; Tayyar AT
J Obstet Gynaecol; 2018 Aug; 38(6):828-832. PubMed ID: 29537325
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North America.
Nelson A; Parke S; Mellinger U; Zampaglione E; Schmidt A
J Womens Health (Larchmt); 2014 Mar; 23(3):204-10. PubMed ID: 24279594
[TBL] [Abstract][Full Text] [Related]
47. Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding.
Wasiak R; Filonenko A; Vanness DJ; Law A; Jeddi M; Wittrup-Jensen KU; Stull DE; Siak S; Jensen JT
J Womens Health (Larchmt); 2013 Apr; 22(4):378-84. PubMed ID: 23586801
[TBL] [Abstract][Full Text] [Related]
48. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
Haverinen AH; Luiro KM; Szanto T; Kangasniemi MH; Hiltunen L; Sainio S; Piltonen TT; Lassila R; Tapanainen JS; Heikinheimo O
Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1102-1111. PubMed ID: 35909329
[TBL] [Abstract][Full Text] [Related]
49. Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial.
Kangasniemi MH; Haverinen A; Luiro K; Hiltunen JK; Komsi EK; Arffman RK; Heikinheimo O; Tapanainen JS; Piltonen TT
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303765
[TBL] [Abstract][Full Text] [Related]
50. [Association of E2v/DNG as contraceptive choice for a better quality of life of women].
Nappi RE
Minerva Ginecol; 2012 Feb; 64(1):41-52. PubMed ID: 22334230
[TBL] [Abstract][Full Text] [Related]
51. Ethinyl estradiol vs estradiol valerate in combined oral contraceptives - Effect on glucose tolerance: A randomized, controlled clinical trial.
Haverinen A; Kangasniemi M; Luiro K; Piltonen T; Heikinheimo O; Tapanainen JS
Contraception; 2021 Jan; 103(1):53-59. PubMed ID: 33098852
[TBL] [Abstract][Full Text] [Related]
52. Review of clinical experience with estradiol in combined oral contraceptives.
Fruzzetti F; Bitzer J
Contraception; 2010 Jan; 81(1):8-15. PubMed ID: 20004267
[TBL] [Abstract][Full Text] [Related]
53. Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
Grinspoon SK; Friedman AJ; Miller KK; Lippman J; Olson WH; Warren MP
J Clin Endocrinol Metab; 2003 Aug; 88(8):3651-6. PubMed ID: 12915650
[TBL] [Abstract][Full Text] [Related]
54. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Thorneycroft lH; Gollnick H; Schellschmidt I
Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
[TBL] [Abstract][Full Text] [Related]
55. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
Fraser IS; Jensen J; Schaefers M; Mellinger U; Parke S; Serrani M
Contraception; 2012 Aug; 86(2):96-101. PubMed ID: 22240178
[TBL] [Abstract][Full Text] [Related]
56. Clinical experience with a new norgestimate-containing oral contraceptive.
Huber J
Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
[TBL] [Abstract][Full Text] [Related]
57. Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol.
Grandi G; Piacenti I; Volpe A; Cagnacci A
Gynecol Endocrinol; 2014 Sep; 30(9):676-80. PubMed ID: 24918262
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Gräser T; Koytchev R; Müller A; Oettel M
Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
[TBL] [Abstract][Full Text] [Related]
59. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
Kangasniemi MH; Arffman RK; Joenväärä S; Haverinen A; Luiro K; Tohmola T; Renkonen R; Heikinheimo O; Tapanainen JS; Piltonen TT
Hum Reprod; 2023 Jan; 38(1):89-102. PubMed ID: 36416543
[TBL] [Abstract][Full Text] [Related]
60. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
Gynecol Endocrinol; 2001 Oct; 15(5):349-58. PubMed ID: 11727357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
